Global On-Body Delivery System (OBDS) Market Growth 2025-2031

Publication ID:

LPI06255800

Publication Date:

June 6, 2025

Pages:

102

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global On-Body Delivery System (OBDS) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The on-body delivery system (OBDS) market is changing rapidly, and it has become clear that OBDS are critical to the delivery of some new drugs in development. The OBDS market is relatively young, which lends itself to exciting innovations and high potential growth rate. Many companies have products that are still in development and have not yet been commercialized.
The 鈥淥n-Body Delivery System (OBDS) Industry Forecast鈥� looks at past sales and reviews total world On-Body Delivery System (OBDS) sales in 2024, providing a comprehensive analysis by region and market sector of projected On-Body Delivery System (OBDS) sales for 2025 through 2031. With On-Body Delivery System (OBDS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world On-Body Delivery System (OBDS) industry.
This Insight Report provides a comprehensive analysis of the global On-Body Delivery System (OBDS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on On-Body Delivery System (OBDS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global On-Body Delivery System (OBDS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for On-Body Delivery System (OBDS) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global On-Body Delivery System (OBDS).
This report presents a comprehensive overview, market shares, and growth opportunities of On-Body Delivery System (OBDS) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Push Drug Out Of Container
Pull Drug Out Of Container
Segmentation by Application:
Diabetes
Parkinson'S Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
West Pharmaceutical Services
Gerresheimer
Stevanato Group
Enable Injections
Insulet
Ypsomed
Bexson
Nemera
BD Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global On-Body Delivery System (OBDS) market?
What factors are driving On-Body Delivery System (OBDS) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do On-Body Delivery System (OBDS) market opportunities vary by end market size?
How does On-Body Delivery System (OBDS) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global On-Body Delivery System (OBDS) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for On-Body Delivery System (OBDS) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for On-Body Delivery System (OBDS) by Country/Region, 2020, 2024 & 2031
2.2 On-Body Delivery System (OBDS) Segment by Type
2.2.1 Push Drug Out Of Container
2.2.2 Pull Drug Out Of Container
2.3 On-Body Delivery System (OBDS) Sales by Type
2.3.1 Global On-Body Delivery System (OBDS) Sales Market Share by Type (2020-2025)
2.3.2 Global On-Body Delivery System (OBDS) Revenue and Market Share by Type (2020-2025)
2.3.3 Global On-Body Delivery System (OBDS) Sale Price by Type (2020-2025)
2.4 On-Body Delivery System (OBDS) Segment by Application
2.4.1 Diabetes
2.4.2 Parkinson'S Disease
2.4.3 Cancer
2.4.4 Cardiovascular Diseases
2.4.5 Other
2.5 On-Body Delivery System (OBDS) Sales by Application
2.5.1 Global On-Body Delivery System (OBDS) Sale Market Share by Application (2020-2025)
2.5.2 Global On-Body Delivery System (OBDS) Revenue and Market Share by Application (2020-2025)
2.5.3 Global On-Body Delivery System (OBDS) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global On-Body Delivery System (OBDS) Breakdown Data by Company
3.1.1 Global On-Body Delivery System (OBDS) Annual Sales by Company (2020-2025)
3.1.2 Global On-Body Delivery System (OBDS) Sales Market Share by Company (2020-2025)
3.2 Global On-Body Delivery System (OBDS) Annual Revenue by Company (2020-2025)
3.2.1 Global On-Body Delivery System (OBDS) Revenue by Company (2020-2025)
3.2.2 Global On-Body Delivery System (OBDS) Revenue Market Share by Company (2020-2025)
3.3 Global On-Body Delivery System (OBDS) Sale Price by Company
3.4 Key Manufacturers On-Body Delivery System (OBDS) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers On-Body Delivery System (OBDS) Product Location Distribution
3.4.2 Players On-Body Delivery System (OBDS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for On-Body Delivery System (OBDS) by Geographic Region
4.1 World Historic On-Body Delivery System (OBDS) Market Size by Geographic Region (2020-2025)
4.1.1 Global On-Body Delivery System (OBDS) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global On-Body Delivery System (OBDS) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic On-Body Delivery System (OBDS) Market Size by Country/Region (2020-2025)
4.2.1 Global On-Body Delivery System (OBDS) Annual Sales by Country/Region (2020-2025)
4.2.2 Global On-Body Delivery System (OBDS) Annual Revenue by Country/Region (2020-2025)
4.3 Americas On-Body Delivery System (OBDS) Sales Growth
4.4 APAC On-Body Delivery System (OBDS) Sales Growth
4.5 Europe On-Body Delivery System (OBDS) Sales Growth
4.6 Middle East & Africa On-Body Delivery System (OBDS) Sales Growth
5 Americas
5.1 Americas On-Body Delivery System (OBDS) Sales by Country
5.1.1 Americas On-Body Delivery System (OBDS) Sales by Country (2020-2025)
5.1.2 Americas On-Body Delivery System (OBDS) Revenue by Country (2020-2025)
5.2 Americas On-Body Delivery System (OBDS) Sales by Type (2020-2025)
5.3 Americas On-Body Delivery System (OBDS) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC On-Body Delivery System (OBDS) Sales by Region
6.1.1 APAC On-Body Delivery System (OBDS) Sales by Region (2020-2025)
6.1.2 APAC On-Body Delivery System (OBDS) Revenue by Region (2020-2025)
6.2 APAC On-Body Delivery System (OBDS) Sales by Type (2020-2025)
6.3 APAC On-Body Delivery System (OBDS) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe On-Body Delivery System (OBDS) by Country
7.1.1 Europe On-Body Delivery System (OBDS) Sales by Country (2020-2025)
7.1.2 Europe On-Body Delivery System (OBDS) Revenue by Country (2020-2025)
7.2 Europe On-Body Delivery System (OBDS) Sales by Type (2020-2025)
7.3 Europe On-Body Delivery System (OBDS) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa On-Body Delivery System (OBDS) by Country
8.1.1 Middle East & Africa On-Body Delivery System (OBDS) Sales by Country (2020-2025)
8.1.2 Middle East & Africa On-Body Delivery System (OBDS) Revenue by Country (2020-2025)
8.2 Middle East & Africa On-Body Delivery System (OBDS) Sales by Type (2020-2025)
8.3 Middle East & Africa On-Body Delivery System (OBDS) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of On-Body Delivery System (OBDS)
10.3 Manufacturing Process Analysis of On-Body Delivery System (OBDS)
10.4 Industry Chain Structure of On-Body Delivery System (OBDS)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 On-Body Delivery System (OBDS) Distributors
11.3 On-Body Delivery System (OBDS) Customer
12 World Forecast Review for On-Body Delivery System (OBDS) by Geographic Region
12.1 Global On-Body Delivery System (OBDS) Market Size Forecast by Region
12.1.1 Global On-Body Delivery System (OBDS) Forecast by Region (2026-2031)
12.1.2 Global On-Body Delivery System (OBDS) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global On-Body Delivery System (OBDS) Forecast by Type (2026-2031)
12.7 Global On-Body Delivery System (OBDS) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 West Pharmaceutical Services
13.1.1 West Pharmaceutical Services Company Information
13.1.2 West Pharmaceutical Services On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.1.3 West Pharmaceutical Services On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 West Pharmaceutical Services Main Business Overview
13.1.5 West Pharmaceutical Services Latest Developments
13.2 Gerresheimer
13.2.1 Gerresheimer Company Information
13.2.2 Gerresheimer On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.2.3 Gerresheimer On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Gerresheimer Main Business Overview
13.2.5 Gerresheimer Latest Developments
13.3 Stevanato Group
13.3.1 Stevanato Group Company Information
13.3.2 Stevanato Group On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.3.3 Stevanato Group On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Stevanato Group Main Business Overview
13.3.5 Stevanato Group Latest Developments
13.4 Enable Injections
13.4.1 Enable Injections Company Information
13.4.2 Enable Injections On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.4.3 Enable Injections On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Enable Injections Main Business Overview
13.4.5 Enable Injections Latest Developments
13.5 Insulet
13.5.1 Insulet Company Information
13.5.2 Insulet On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.5.3 Insulet On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Insulet Main Business Overview
13.5.5 Insulet Latest Developments
13.6 Ypsomed
13.6.1 Ypsomed Company Information
13.6.2 Ypsomed On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.6.3 Ypsomed On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ypsomed Main Business Overview
13.6.5 Ypsomed Latest Developments
13.7 Bexson
13.7.1 Bexson Company Information
13.7.2 Bexson On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.7.3 Bexson On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bexson Main Business Overview
13.7.5 Bexson Latest Developments
13.8 Nemera
13.8.1 Nemera Company Information
13.8.2 Nemera On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.8.3 Nemera On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nemera Main Business Overview
13.8.5 Nemera Latest Developments
13.9 BD Medical
13.9.1 BD Medical Company Information
13.9.2 BD Medical On-Body Delivery System (OBDS) Product Portfolios and Specifications
13.9.3 BD Medical On-Body Delivery System (OBDS) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BD Medical Main Business Overview
13.9.5 BD Medical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂